CONNECTING CLIENTS + PAYERS
Private and Provincial funding markets for pharmaceuticals, medical devices and diagnostics continue to rapidly evolve in response to concerns over balancing long-term sustainability, fiscal responsibility, therapeutic gaps, innovation, and increasing therapeutic options in rare diseases. WestPAR has the understanding, knowledge and skill set required to help you achieve your goals in Western Canada.
Health Policy spans our work with pharmaceuticals, medical devices and diagnostics from both a funding and access perspective. WestPAR has substantial experience in working collaboratively with governments in Western Canada to shift and reconfigure Policy to meet the emerging needs and realities of our evolving healthcare system.
Innovation often creates new system challenges and barriers to access and funding. Having an experienced partner is critical to developing the appropriate strategy, acquiring guidance, and building collaborative consensus with government decision and policy makers.
WestPAR is strategically positioned to help provide the expertise, knowledge, understanding, and networks required to bring suppliers and payers together, as they both seek creative sustainable funding/access solutions.
PHARMACEUTICALS
The West presents many unique funding, access, and program challenges. WestPAR provides the expertise, presence, and understanding to orchestrate creative funding solutions.
WestPAR is uniquely positioned to provide an integrated set of market access and reimbursement strategic services specific to Western Canadian. Based in Vancouver and operating across the four western provinces, has afforded the opportunity to develop expertise, presence, intimate knowledge, and understanding of this segment of the market while cultivating trusted relationships with key contacts.
Our services extend across the spectrum of therapeutic areas and the highly specialized funding programs of Western Canada.
MEDICAL DEVICES
The Canadian Medical Device funding model is more fragmented and program driven. WestPAR provides the expertise, research, and strategy required to secure funding.
Medical Devices offer many unique Public and Private Payer Funding challenges in Canada due to coverage being more fragmented and program driven. WestPAR is adept at conducting the required research and investigations to develop creative strategies for navigating the Provincial, Federal and Private Payer funding environments. We are experienced in addressing access and reimbursement needs for medical devices in various stages of their lifecycle from pre-approval through to well-established products.
DIAGNOSTICS
Genomics, phenotyping and point-of-access testing are challenging the system. WestPAR extends value propositions to consider the broader impact of diagnostics.
Diagnostics are playing a far greater role in healthcare. Genomics, phenotyping and point-of-access testing are challenging the standard diagnostic model, their role, access, system process, and data. Coupled with these challenges are treatment, funding, system implications and policy.
WestPAR is experienced in developing funding strategies that extend beyond the product to consider the broader impact and role of diagnostics. Creative collaborative solutions are needed to broker the environment and willingness required to encourage funding.
PAYER AND SUPPLIER COMBINED MARKET PRESSURES
The combined market pressures are driving both Payers and Suppliers to seek creative, innovative, sustainable solutions. The need for different solutions is driving the shift to pay-for-performance and outcomes-based funding models, big-data, more expansive risk-sharing, supplier/supplier and supplier/payer collaboration, and other creative solutions.
EXPERTISE
RESEARCH
Market Research Clinical / Therapeutic Research Environment Scans Influence Mapping
STRATEGY
Collaborative Approach Western Public Payer National Private Payer Western Lead pCPA
SUBMISSIONS
Western Provincial Public Payers National Private Payers Hospital
ADVOCACY
Public + Private Payer Meetings Provincial Ministries + MLAs Patient Group Engagement Comprehensive Campaigns
NEGOTIATIONS
Western Public Payers PLAs National Private Payer PLAs Western Lead pCPA Western Provincial LOls
RESEARCH
Market Research Clinical / Therapeutic Research Environment Scans Influence Mapping
STRATEGY
Collaborative Approach Western Public Payer National Private Payer Western Lead pCPA
SUBMISSIONS
Western Provincial Public Payers National Private Payers Hospital
ADVOCACY
Public + Private Payer Meetings Provincial Ministries + MLAs Patient Group Engagement Comprehensive Campaigns
NEGOTIATIONS
Western Public Payers PLAs National Private Payer PLAs Western Lead pCPA Western Provincial LOls
CAPABILITIES
WESTERN CANADA
- Reimbursement and Access Strategy
- Provincial Submissions
- Hospital Formulary Submissions
- Budget Impact Analysis (BIA) Modeling
- Payer Negotiations
- Payer Tours and Meetings
- Environmental Scans
- Influence Mapping
- Advisory Boards
- Advocacy, KOL + Patient
- Product Listing Agreements
NATIONAL
- pCPA Engagement Strategy Western Perspective
- pCPA Negotiations with Western Lead Provinces
- Budget Impact Analysis (BIA) Modeling
- pCPA specific BIA Modeling
- Market Impact Modeling
- Environmental Scans
- Influence Mapping
- Private Payer Submissions
- Private Payer Negotiations
THROUGH OUR STRATEGIC PARTNERS AND ALLIANCES
- PMPRB Pricing Strategy
- CDR Submissions (CAT I + II)
- pCPA Strategy + Negotiations
- Pharmacoeconomic Studies + Analysis
- Ontario + Quebec Specific Access, Funding and Policy Issues